オリゴヌクレオチドベースの医薬品の可能性に、ようやくその価値に見合った注目が集まっています。Bachemは新たなイノベーションをもたらし、弊社顧客、ひいては患者様のクオリティ・オブ・ライフの向上に貢献します。
添付のデリバリーシステムである細胞透過性ペプチド(CPP)についての記事をぜひご参照ください。
Oligonucleotides are very promising and versatile therapeutics for rare and genetic diseases. They act on the RNA level through different molecular pathways that we already have described in a precedent article. Because of their mechanism of action, this class of therapeutics has huge possibilities to treat diseases that were incurable before. The use of oligonucleotide therapeutics is well tolerated by the body, selective to their target, and with reduced secondary effects. Despites their huge potential and attractiveness as a treatment, there is a major drawback when dealing with oligonucleotides as drugs: their poor bioavailability and cellular uptake. These aspects are the main limitations for their application as therapeutics. To address these drawbacks, it seems of utmost importance to develop delivery systems that enable oligonucleotides to reach their targets. In a previous article on oligonucleotide conjugates, we have described the use of the trimeric GalNAc (N-acetylgalactosamine) molecule as a carrier of oligonucleotides to specific cells, the hepatocytes. Here, we discuss a delivery system that have been in vogue since almost 40 years, the cell-penetrating peptides (CPP). The first use of CPP, a poly L-lysine, has been described for the delivery of an anticancer drug in vitro and in vivo of mouse model1. It has opened the way for generation of CPP-drug conjugates and has potential as well for oligonucleotides2.
- WEB展示場 TOP
- バッケムジャパン株式会社
- CELL-PENETRATING PEPTIDES: A DELIVERY SYSTEM FOR OLIGONUCLEOTIDES
企業情報
バッケムジャパン株式会社
- 住所東京都中央区日本橋堀留町1-9-10 上野ビル8階
- TEL03-6661-0774
- URLhttps://www.bachem.com/webinars/
その他の新着リリース
-
コラム「【詳説】CAR-T細胞療法の原理と企業による開発の最先端 ~ユニバーサルCAR-Tが費用の問題を解決」をリリースしました
TechnoProducer株式会社 2024/10/04 - 株式会社ユニオンシンク 2024/10/04
-
【ダイダン】再生医療JAPAN2024に出展します(10/9-10/11)
ダイダン株式会社(セラボヘルスケアサービス株式会社) 2024/10/03 - 株式会社ワイエムシィ 2024/10/03
-
【記事掲載】日本経済新聞にNIR錠剤検査装置の記事が掲載されました
アンリツ株式会社 2024/10/03